Author
Listed:
- Matthew J. Seasock
(Baylor College of Medicine
Baylor College of Medicine)
- Md Shafiquzzaman
(Baylor College of Medicine)
- Maria E. Ruiz-Echartea
(Baylor College of Medicine)
- Rupa S. Kanchi
(Baylor College of Medicine
Baylor College of Medicine)
- Brandon T. Tran
(Baylor College of Medicine
Baylor College of Medicine)
- Lukas M. Simon
(Baylor College of Medicine)
- Matthew D. Meyer
(Rice University)
- Phillip A. Erice
(Baylor College of Medicine
Baylor College of Medicine)
- Shivani L. Lotlikar
(Baylor College of Medicine)
- Stephanie C. Wenlock
(University of Cambridge)
- Scott A. Ochsner
(Baylor College of Medicine)
- Anton Enright
(University of Cambridge)
- Alex F. Carisey
(Texas Children’s Hospital
St. Jude Children’s Research Hospital)
- Freddy Romero
(Baylor College of Medicine
3215 Merryfield Row)
- Ivan O. Rosas
(Baylor College of Medicine)
- Katherine Y. King
(Baylor College of Medicine)
- Neil J. McKenna
(Baylor College of Medicine)
- Cristian Coarfa
(Baylor College of Medicine
Baylor College of Medicine)
- Antony Rodriguez
(Baylor College of Medicine
Baylor College of Medicine
Baylor College of Medicine)
Abstract
MicroRNA-mediated post-transcriptional regulation of lung alveolar type 2 (AT2) and AT1 cell differentiation remains understudied. Here, we demonstrate that the let-7 miRNA family plays a homeostatic role in AT2 quiescence by preventing the uncontrolled accumulation of AT2 transitional cells and promoting AT1 differentiation. Using mouse and organoid models, we show that genetic ablation of let-7a1/let-7f1/let-7d cluster (let-7afd) in AT2 cells prevents AT1 differentiation and leads to KRT8 transitional cell accumulation in progressive pulmonary fibrosis. Integration of AGO2-eCLIP with RNA-sequencing identified direct let-7 targets within an oncogene feed-forward regulatory network, including BACH1/EZH2/MYC, which drives an aberrant fibrotic cascade. Additional CUT&RUN-sequencing analyses revealed that let-7afd loss disrupts histone acetylation and methylation, driving epigenetic reprogramming and altered gene transcription in profibrotic AT2 cells. This study identifies let-7 as a central hub linking unchecked oncogenic signaling to impaired AT2 cell plasticity and fibrogenesis.
Suggested Citation
Matthew J. Seasock & Md Shafiquzzaman & Maria E. Ruiz-Echartea & Rupa S. Kanchi & Brandon T. Tran & Lukas M. Simon & Matthew D. Meyer & Phillip A. Erice & Shivani L. Lotlikar & Stephanie C. Wenlock & , 2025.
"Let-7 restrains an epigenetic circuit in AT2 cells to prevent fibrogenic intermediates in pulmonary fibrosis,"
Nature Communications, Nature, vol. 16(1), pages 1-20, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-59641-1
DOI: 10.1038/s41467-025-59641-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-59641-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.